Male pattern baldness is largely driven by sensitivity to DHT. In genetically predisposed men, DHT binds to hair follicles and causes them to gradually shrink (a process known as miniaturisation). Over time, hair becomes finer and shorter, eventually leading to visible thinning.

Dutasteride works by inhibiting both type I and type II 5-alpha-reductase enzymes. These enzymes convert testosterone into DHT. By reducing DHT production, dutasteride may help slow the progression of hair thinning in suitable patients.

It is important to understand:

-Treatment must be ongoing to maintain effect
-Results vary between individuals
-It does not create new hair follicles
-Visible changes can take several months

Finasteride 1mg is licensed in the UK for male pattern hair loss and is typically the first-line oral treatment option.

Dutasteride reduces DHT levels through inhibition of two enzyme pathways, whereas finasteride inhibits one. A prescriber will assess whether dutasteride is appropriate based on your medical history and treatment response.

We generally recommend that men consider finasteride before exploring dutasteride.

-For adult men aged 18 and over only
-Not licensed in the UK for male pattern baldness
-Must not be taken by women
-Capsules must not be handled by women who are pregnant or may become pregnant
-Not suitable for individuals with certain liver conditions

Always follow the advice of your prescriber and read the patient information leaflet supplied with your medication.